Dermatitis
Ruxolitinib cream improves sleep disturbances, itch in children with atopic dermatitis
SAN DIEGO — Ruxolitinib cream improved quality of life outcomes, including sleep and itch, in children aged 2 to 11 years with atopic dermatitis, according to a poster presented at the American Academy of Dermatology Annual Meeting.
ChatGPT may potentially improve patch testing efficiency for allergic contact dermatitis
SAN DIEGO — While it did not perform at the level of clinicians, ChatGPT could be used as a tool to improve patch testing efficiency for allergic contact dermatitis, according to a poster presentation here.
Lebrikizumab shows early efficacy in atopic dermatitis for patients with skin of color
SAN DIEGO — Atopic dermatitis improvement was found with lebrikizumab treatment in patients with skin of color, according to interim study results presented at the American Academy of Dermatology Annual Meeting.
Nemolizumab shows long-term efficacy in treatment of prurigo nodularis, atopic dermatitis
SAN DIEGO — At the American Academy of Dermatology Annual Meeting, Galderma announced new data demonstrating nemolizumab’s long-term efficacy in treating prurigo nodularis and atopic dermatitis, according to a press release.
Roflumilast improves atopic dermatitis symptoms in children aged 2 to 5 years
SAN DIEGO — In children aged 2 to 5 years with atopic dermatitis, roflumilast cream 0.05% significantly improved symptoms compared with vehicle, with improvement seen as early as 1 week after treatment, according to a speaker here.
Vtama cream achieves consistent efficacy in atopic dermatitis across racial groups
SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.
Skin microbiota predicts atopic dermatitis in infants
WASHINGTON — Atopic dermatitis can be predicted in children aged as young as 6 months with skin microbiome and metabolome signatures, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Patients with atopic dermatitis maintain improvements for up to 2 years with lebrikizumab
WASHINGTON — Patients with moderate to severe atopic dermatitis treated with lebrikizumab maintained improvements in patient-reported outcomes, according to a poster presented here.
Liquid synthetic detergents may be better cleansers for patients with atopic dermatitis
WASHINGTON — Patients with atopic dermatitis may have better outcomes when using liquid synthetic detergents, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Early non-lesional filaggrin expression predicts childhood asthma in atopic dermatitis
WASHINGTON — Among children with atopic dermatitis, low non-lesional skin filaggrin expression during early ages predicted future asthma, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.